?1 prior regimen of chemotherapy for State-of-the-art breast cancer and throughout the complete trial, past publicity to any FGFR inhibitor, important surgical procedures or radiotherapy within 4 weeks before very first dose of examine therapy and using potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac conditions precl